There is significant growth in the Digital Biomarkers Market due to the increasing focus of pharmaceutical companies, healthcare providers, and research institutions on real-time patient monitoring, remote diagnostics, and precision medicine across chronic disease, neurology, and oncology applications. The rising penetration of wearable devices, mobile health platforms, cloud-based analytics, and AI-driven behavioral and cognitive assessments are reshaping how patient data is captured, validated, and used in clinical decision-making.
The global Digital Biomarkers Market was valued at USD 5.84 Billion in 2025 and is expected to reach USD 35.83 Billion by 2035, growing at a CAGR of 19.89% during the forecast period 2026-2035. Several factors are driving growth in the Digital Biomarkers Market such as the growing installed base of wearable and connected health devices, rising integration of digital endpoints in decentralized clinical trials, increasing demand for cognitive and vocal biomarkers in neurology and mental health, and expanding cloud-based deployment of biomarker platforms.
Gain Actionable Intelligence on the Digital Biomarkers Market – Request a Sample Report
Some of the major companies operating in the Digital Biomarkers Market are Apple Inc., Alphabet Inc. (Google Fit, Verily), Microsoft Corporation, Samsung Electronics Co., Ltd., Fitbit (Google), Garmin Ltd., Medtronic plc, Abbott Laboratories, Koninklijke Philips N.V., ResMed Inc., AliveCor, Inc., Oura Health Ltd., Withings SA, Biofourmis Inc., Evidation Health, Inc., and others.
Strategic Developments & Industry Innovations
- Apple’s Watch received FDA approval for a hypertension detection feature in September 2025, launched globally across the Series 9, 10, 11, and Ultra models.
- Verily (Alphabet) introduced its Numetric Watch in August 2025, enabling real-time, multi-language biomarker data entry for clinical trials across diverse patient groups.
- Microsoft expanded its Azure Health AI platform in July 2025 to support digital biomarkers across more than 500 clinical trials, enhancing neurology and cardiology endpoints.
Top Players Driving Innovation in the Digital Biomarkers Market:
1. Apple Inc.: Advancing Consumer-Grade Health Monitoring
Digital Biomarkers Market includes Apple Inc., which is a key player in this market through its product offerings like Apple Watch and Health, that provide continuous physiological and behavioral data including heart rate, movement, sleep, and ECG. Apple’s continuous endeavors in developing FDA-approved healthcare technologies, along with mass adoption and involvement in clinical studies, place it as a key player in digital biomarker adoption across the globe.
2. Alphabet Inc.: Scaling Biomarker Research Through Verily and Fitbit
The leaders in digital biomarkers are Alphabet’s Verily, Fitbit, and Google Fit. All these companies use a foundation of more than 100 million Fitbit users across the globe. Their initiatives of Project Baseline and Study Watch have clocked in more than 500 million biomarker hours in the making of precision medicine. These organizations have formed partnerships with various companies such as Novartis, Pfizer, and Dexcom with the help of AI infrastructure from Google Cloud.
3. Microsoft Corporation: Powering Biomarker Infrastructure at Scale
The influence of Microsoft is immense with the support provided to more than 3,000 healthcare institutions for validated biomarkers in neuroscience and cardiovascular disease studies. Partnerships with Novartis and Adaptive Biotechnologies as well as Azure Analytics usage by 95% of Fortune 500 healthcare corporations keep Microsoft in the lead in terms of digital biomarker infrastructure
Advancing Precision Medicine Through Innovation in the Digital Biomarkers Market
The Digital Biomarkers Market is set to witness steady growth owing to the incorporation of wearables, mobile devices, and AI-powered analysis in pharma companies, healthcare organizations, and research institutions. The growth in the market is expected to come from technological developments in decentralized clinical trials, cognitive/vocal biomarkers, and cloud-hybrid deployments.
Prominent firms in the market are Apple Inc., Alphabet Inc., and Microsoft Corporation. These firms have been instrumental in bringing about technological advancements in the field of digital biomarkers via innovative wearable devices, health clouds, and clinically proven biomarker solutions. With pharmaceutical firms and healthcare firms increasingly paying attention to real-time monitoring and faster drug development cycles, digital biomarkers will prove vital for precision medicine in the coming years.
